Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction

Cell Transplantation

Volumn 15, Issue 4, 2006, Pages 295-309

  Merani, Shaheed ^a   Truong, Wayne W ^a   Hancock, Wayne ^b   Anderson, Colin C ^a   Shapiro, A M James ^a,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Allograft; Chemokine; Islet; Review; Tolerance; Transplant

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR;

CELL SURFACE; CYTOKINE RELEASE; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULITIS; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

CHEMOKINES; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; ISLETS OF LANGERHANS TRANSPLANTATION; LEUKOCYTES; RECEPTORS, CHEMOKINE; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 33746768157     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000006783981963     Document Type: Review

References (121)

1. Abdi, R.; Means, T. K.; Ito, T.; Smith, R. N.; Najafian, N.; Jurewicz, M.; Tchipachvili, V.; Charo, I.; Auchincloss, Jr., H.; Sayegh, M. H.; et al. Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo. J. Immunol. 172(2):767-775; 2004.
2. Abdi, R.; Means, T. K.; Luster, A. D. Chemokines in islet allograft rejection. Diabetes Metab. Res. Rev. 19(3):186-190; 2003.
3. Abdi, R.; Smith, R. N.; Makhlouf, L.; Najafian, N.; Luster, A. D.; Auchincloss, Jr., H.; Sayegh, M. H. The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection. Diabetes 51(8):2489-2495; 2002.
4. Aikin, R.; Rosenberg, L.; Paraskevas, S.; Maysinger, D. Inhibition of caspase-mediated PARP-1 cleavage results in increased necrosis in isolated islets of Langerhans. J. Mol. Med. 82(6):389-397; 2002.
5. Ameixa, C.; Friedland, J. S. Interleukin-8 secretion from mycobacterium tuberculosis-infected monocytes is regulated by protein tyrosine kinases but not by ERK1/2 or p38 mitogen-activated protein kinases. Infect. Immun. 70(8):4743-4746; 2002.
6. Anders, H. J.; Vielhauer, V.; Frink, M.; Linde, Y.; Cohen, C. D.; Blattner, S. M.; Kretzler, M.; Strutz, F.; Mack, M.; Grone, H. J.; et al. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J. Clin. Invest. 109(2):251-259; 2002.
7. Arakaki, R.; Tamamura, H.; Premanathan, M.; Kanbara, K.; Ramanan, S.; Mochizuki, K.; Baba, M.; Fujii, N.; Nakashima, H. T134, a small-molecule CXCR4 inhibitor, has no cross-drug resistance with AMD3100, a CXCR4 antagonist with a different structure. J. Virol. 73(2):1719-1723; 1999.
8. Armengol, M. P.; Cardoso-Schmidt, C. B.; Fernandez, M.; Ferrer, X.; Pujol-Borrell, R.; Juan, M. Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases. J. Immunol. 170(12):6320-6328; 2003.
9. Asano, M.; Toda, M.; Sakaguchi, N.; Sakaguchi, S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184(2):387-396; 1996.
10. Azevedo-Martins, A. K.; Lortz, S.; Lenzen, S.; Curi, R.; Eizirik, D. L.; Tiedge, M. Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor-kappaB activation in insulin-producing cells. Diabetes 52(1):93-101; 2003.
11. Baba, M.; Nishimura, O.; Kanzaki, N.; Okamoto, M.; Sawada, H.; Iizawa, Y.; Shiraishi, M.; Aramaki, Y.; Okonogi, K.; Ogawa, Y.; et al. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc. Natl. Acad. Sci. USA 96(10):5698-5703; 1999.
12. Baggiolini, M.; Dewald, B.; Moser, B. Human chemokines: An update. Annu. Rev. Immunol. 15:675-705; 1997.
13. Baker, M. S.; Chen, X.; Rotramel, A. R.; Nelson, J. J.; Lu, B.; Gerard, C.; Kanwar, Y.; Kaufman, D. B. Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients. Surgery 134(2):126-133; 2003.
14. Beckmann, J. H.; Yan, S.; Luhrs, H.; Heid, B.; Skubich, S.; Forster, R.; Hoffmann, M. W. Prolongation of allograft survival in ccr7-deficient mice. Transplantation 77(12):1809-1814; 2004.
15. Bedke, J.; Stojanovic, T.; Grone, H. J.; Heuser, M.; Scheele, L.; Proudfoot, A. E.; Becker, H.; Markus, P. M.; Hecker, M. Met-RANTES improves acute-rejection-induced microvascular injury in rat small bowel transplantation. Transplant. Proc. 34(3):1049; 2002.
16. Bretzel, R. G.; Brendel, M.; Eckhard, M.; Brandhorst, D.; Jaeger, C.; Hatziagelaki, E.; Federlin, K. Islet transplantation: Present clinical situation and future aspects. Exp. Clin. Endocrinol. Diabetes 109(Suppl. 2):S384-S399; 2001.
17. Brinkmann, V.; Pinschewer, D. D.; Feng, L.; Chen, S. FTY720: Altered lymphocyte traffic results in allograft protection. Transplantation 72(5):764-769; 2001.
18. Campbell, J. J.; Foxman, E. F.; Butcher, E. C. Chemoattractant receptor cross talk as a regulatory mechanism in leukocyte adhesion and migration. Eur. J. Immunol. 27(10):2571-2578; 1997.
19. Carvalho-Pinto, C.; Garcia, M. I.; Gomez, L.; Ballesteros, A.; Zaballos, A.; Flores, J. M.; Mellado, M.; Rodriguez-Frade, J. M.; Balomenos, D.; Martinez, A. C. Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice. Eur. J. Immunol. 34(2):548-557; 2004.
20. Chen, D.; Ding, Y.; Schroppel, B.; Zhang, N.; Fu, S.; Zhang, H.; Bromberg, J. S. Differential chemokine and chemokine receptor gene induction by ischemia, alloantigen, and gene transfer in cardiac grafts. Am. J. Transplant. 3(10):1216-1229; 2003.
21. Christen, U.; von Herrath, M. G. IP-10 and type 1 diabetes: A question of time and location. Autoimmunity 37(4):273-282; 2004.
22. Christopherson, 2nd, K. W.; Campbell, J. J.; Travers, J. B.; Hromas, R. A. Low-molecular-weight heparins inhibit CCL21-induced T cell adhesion and migration. J. Pharmacol. Exp. Ther. 302(1):290-295; 2002.
23. Clark-Lewis, I.; Mattioli, I.; Gong, J. H.; Loetscher, P. Structure-function relationship between the human chemokine receptor CXCR3 and its ligands. J. Biol. Chem. 278(1):289-295; 2003.
24. Coates, F.; Colvin, B. L.; Kaneko, K.; Taner, T.; Thomson, A. W. Pharmacologic, biologic, and genetic engineering approaches to potentiation of donor-derived dendritic cell tolerogenicity. Transplantation 75(9 Suppl.):32S-36S; 2003.
25. Cravens, P. D.; Lipsky, P. E. Dendritic cells, chemokine receptors and autoimmune inflammatory diseases. Immunol. Cell Biol. 80(5):497-505; 2002.
26. De Clercq, E. The bicyclam AMD3100 story. Nat. Rev. Drug Discov. 2(7):581-587; 2003.
27. de Groot, M.; Schuurs, T. A.; Keizer, P. P.; Fekken, S.; Leuvenink, H. G.; van Schilfgaarde, R. Response of encapsulated rat pancreatic islets to hypoxia. Cell Transplant. 12(8):867-875; 2003.
28. DeVries, M. E.; Hosiawa, K. A.; Cameron, C. M.; Bosinger, S. E.; Persad, D.; Kelvin, A. A.; Coombs, J. C.; Wang, H.; Zhong, R.; Cameron, M. J.; et al. The role of chemokines and chemokine receptors in alloantigen-independent and alloantigen-dependent transplantation injury. Semin. Immunol. 15(1):33-48; 2003.
29. Dragic, T.; Trkola, A.; Thompson, D. A.; Cormier, E. G.; Kajumo, F. A.; Maxwell, E.; Lin, S. W.; Ying, W.; Smith, S. O.; Sakmar, T. P.; et al. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc. Natl. Acad. Sci. USA 97(10):5639-5644; 2000.
30. Ehrnfelt, C.; Kumagai-Braesch, M.; Uzunel, M.; Holgersson, J. Adult porcine islets produce MCP-1 and recruit human monocytes in vitro. Xenotransplantation 11(2):184-194; 2004.
31. Elass, E.; Masson, M.; Mazurier, J.; Legrand, D. Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect. Immun. 70(4):1860-1866; 2002.
32. el-Sawy, T.; Fahmy, N. M.; Fairchild, R. L. Chemokines: Directing leukocyte infiltration into allografts. Curr. Opin. Immunol. 14(5):562-568; 2002.
33. Este, J. A. Sch-351125 and Sch-350634. Schering-Plough. Curr. Opin. Invest. Drugs 3(3):379-383; 2002.
34. Fischereder, M.; Luckow, B.; Hocher, B.; Wuthrich, R. P.; Rothenpieler, U.; Schneeberger, H.; Panzer, U.; Stahl, R. A.; Hauser, I. A.; Budde, K.; et al. CC chemokine receptor 5 and renal-transplant survival. Lancet 357(9270):1758-1761; 2001.
35. Foxman, E. F.; Campbell, J. J.; Butcher, E. C. Multistep navigation and the combinatorial control of leukocyte chemotaxis. J. Cell Biol. 139(5):1349-1360; 1997.
36. Fraker, C.; Montelongo, J.; Szust, J.; Khan, A.; Ricordi, C. The use of multiparametric monitoring during islet cell isolation and culture: A potential tool for in-process corrections of critical physiological factors. Cell Transplant. 13(5):497-502; 2004.
37. Gao, P.; Zhou, X. Y.; Yashiro-Ohtani, Y.; Yang, Y. F.; Sugimoto, N.; Ono, S.; Nakanishi, T.; Obika, S.; Imanishi, T.; Egawa, T.; et al. The unique target specificity of a nonpeptide chemokine receptor antagonist: Selective blockade of two Th1 chemokine receptors CCR5 and CXCR3. J. Leukoc. Biol. 73(2):273-280; 2003.
38. Gao, W.; Topham, P. S.; King, J. A.; Smiley, S. T.; Csizmadia, V.; Lu, B.; Gerard, C. J.; Hancock, W. W. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J. Clin. Invest. 105(1):35-44; 2000.
39. Giarratana, N.; Penna, G.; Amuchastegui, S.; Mariani, R.; Daniel, K. C.; Adorini, L. A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J. Immunol. 173(4):2280-2287; 2004.
40. Goss, J. A.; Schock, A. P.; Brunicardi, F. C.; Goodpastor, S. E.; Garber, A. J.; Soltes, G.; Barth, M.; Froud, T.; Alejandro, R.; Ricordi, C. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center. Transplantation 74(12):1761-1766; 2002.
41. Grone, H. J.; Weber, C.; Weber, K. S.; Grone, E. F.; Rabelink, T.; Klier, C. M.; Wells, T. N.; Proudfood, A. E.; Schlondorff, D.; Nelson, P. J. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: Blocking monocyte arrest and recruitment. FASEB J. 13(11):1371-1383; 1999.
42. Hancock, W. W. Chemokine receptor-dependent alloresponses. Immunol. Rev. 196:37-50; 2003.
43. Hancock, W. W.; Wang, L.; Ye, Q.; Han, R.; Lee, I. Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression. Curr. Opin. Immunol. 15(5):479-486; 2003.
44. Hansel, T. T.; Barnes, P. J. Novel drugs for treating asthma. Curr. Allergy Asthma Rep. 1(2):164-173; 2001.
45. Hering, B. J.; Kandaswamy, R.; Ansite, J. D.; Eckman, P. M.; Nakano, M.; Sawada, T.; Matsumoto, I.; Ihm, S. H.; Zhang, H. J.; Parkey, J.; et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 293(7):830-835; 2005.
46. Hering, B. J.; Kandaswamy, R.; Harmon, J. V.; Ansite, J. D.; Clemmings, S. M.; Sakai, T.; Paraskevas, S.; Eckman, P. M.; Sageshima, J.; Nakano, M.; et al. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am. J. Transplant. 4(3):390-401; 2004.
47. Itoh, M.; Takahashi, T.; Sakaguchi, N.; Kuniyasu, Y.; Shimizu, J.; Otsuka, F.; Sakaguchi, S. Thymus and autoimmunity: Production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162(9):5317-5326; 1999.
48. Janatpour, M. J.; Hudak, S.; Sathe, M.; Sedgwick, J. D.; McEvoy, L. M. Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment. J. Exp. Med. 194(9):1375-1384; 2001.
49. Johansson, U.; Olsson, A.; Gabrielsson, S.; Nilsson, B.; Korsgren, O. Inflammatory mediators expressed in human islets of Langerhans: Implications for islet transplantation. Biochem. Biophys. Res. Commun. 308(3):474-479; 2003.
50. Jonuleit, H.; Schmitt, E.; Steinbrink, K.; Enk, A. H. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 22(7):394-400; 2001.
51. Kalinski, P.; Hilkens, C. M.; Wierenga, E. A.; Kapsenberg, M. L. T-cell priming by type-1 and type-2 polarized dendritic cells: The concept of a third signal. Immunol. Today 20(12):561-567; 1999.
52. Koshiba, T.; Ji, P.; Tanaka, K.; McMaster, P.; Van Damme, B.; Waer, M.; Pirenne, J. Tolerance induction with FTY720 and donor-specific blood transfusion: Discrepancy between heart transplantation and intestinal transplantation. Transplant. Proc. 32(6):1255-1257; 2000.
53. Kunkel, E. J.; Campbell, D. J.; Butcher, E. C. Chemokines in lymphocyte trafficking and intestinal immunity. Microcirculation 10(3-4):313-323; 2003.
54. Lakey, J. R.; Burridge, P. W.; Shapiro, A. M. Technical aspects of islet preparation and transplantation. Transpl. Int. 16(9):613-632; 2003.
55. Lee, I.; Wang, L.; Wells, A. D.; Ye, Q.; Han, R.; Dorf, M. E.; Kuziel, W. A.; Rollins, B. J.; Chen, L.; Hancock, W. W. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism. J. Immunol. 171(12):6929-6935; 2003.
56. Lee, T. H.; Avraham, H.; Lee, S. H.; Avraham, S. Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells. J. Biol. Chem. 277(12):10445-10451; 2002.
57. Lo, H. C.; Lin, S. C.; Wang, Y. M. The relationship among serum cytokines, chemokine, nitric oxide, and leptin in children with type 1 diabetes mellitus. Clin. Biochem. 37(8):666-672; 2003.
58. Loetscher, P.; Uguccioni, M.; Bordoli, L.; Baggiolini, M.; Moser, B.; Chizzolini, C.; Dayer, J. M. CCR5 is characteristic of Th1 lymphocytes. Nature 391(6665):344-345; 1998.
59. Luther, S. A.; Cyster, J. G. Chemokines as regulators of T cell differentiation. Nat. Immunol. 2(2):102-107; 2001.
60. Maeda, K.; Yoshimura, K.; Shibayama, S.; Habashita, H.; Tada, H.; Sagawa, K.; Miyakawa, T.; Aoki, M.; Fukushima, D.; Mitsuya, H. Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5. J. Biol. Chem. 276(37):35194-35200; 2001.
61. Martin-Fontecha, A.; Sebastiani, S.; Hopken, U. E.; Uguccioni, M.; Lipp, M.; Lanzavecchia, A.; Sallusto, F. Regulation of dendritic cell migration to the draining lymph node: Impact on T lymphocyte traffic and priming. J. Exp. Med. 198(4):615-621; 2003.
62. Martin-Fontecha, A.; Thomsen, L. L.; Brett, S.; Gerard, C.; Lipp, M.; Lanzavecchia, A.; Sallusto, F. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 5(12):1260-1265; 2004.
63. Marzorati, S.; Melzi, R.; Nano, R.; Antonioli, B.; Di Carlo, V.; Piemonti, L.; Bertuzzi, F. In vitro modulation of monocyte chemoattractant protein-1 release in human pancreatic islets. Transplant. Proc. 36(3):607-608; 2004.
64. Matzinger, P. The danger model: A renewed sense of self. Science 296(5566):301-305; 2002.
65. Mellado, M.; Rodriguez-Frade, J. M.; Manes, S.; Martinez, A. C. Chemokine signaling and functional responses: The role of receptor dimerization and TK pathway activation. Annu. Rev. Immunol. 19:397-421; 2001.
66. Melter, M.; McMahon, G.; Fang, J.; Ganz, P.; Briscoe, D. M. Current understanding of chemokine involvement in allograft transplantation. Pediatr. Transplant. 3(1):10-21; 1999.
67. Moberg, L.; Olsson, A.; Berne, C.; Felldin, M.; Foss, A.; Kallen, R.; Salmela, K.; Tibell, A.; Tufveson, G.; Nilsson, B.; et al. Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: Implications for clinical islet transplantation. Transplantation 76(9):1285-1288; 2003.
68. Morimoto, J.; Yoneyama, H.; Shimada, A.; Shigihara, T.; Yamada, S.; Oikawa, Y.; Matsushima, K.; Saruta, T.; Narumi, S. CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced {beta} cell proliferation without affecting insulitis. J. Immunol. 173(11):7017-7024; 2004.
69. Moser, B.; Loetscher, P. Lymphocyte traffic control by chemokines. Nat. Immunol. 2(2):123-128; 2001.
70. Moser, B.; Wolf, M.; Walz, A.; Loetscher, P. Chemokines: Multiple levels of leukocyte migration control. Trends Immunol. 25:75-84; 2004.
71. Moser, M.; Murphy, K. M. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 1(3):199-205; 2000.
72. Murphy, P. M. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol. Rev. 54(2):227-229; 2002.
73. Murphy, P. M. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:593-633; 1994.
74. Murphy, P. M.; Baggiolini, M.; Charo, I. F.; Hebert, C. A.; Horuk, R.; Matsushima, K.; Miller, L. H.; Oppenheim, J. J.; Power, C. A. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52(1):145-176; 2000.
75. Nakata, H.; Maeda, K.; Miyakawa, T.; Shibayama, S.; Matsuo, M.; Takaoka, Y.; Ito, M.; Koyanagi, Y.; Mitsuya, H. Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor {gamma}-chain-knocked-out AIDS mouse model. J. Virol. 79(4):2087-2096; 2005.
76. Nelson, P. J.; Krensky, A. M. Chemokines, chemokine receptors, and allograft rejection. Immunity 14(4):377-386; 2001.
77. Ogilvie, P.; Paoletti, S.; Clark-Lewis, I.; Uguccioni, M. Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes. Blood 102(3):789-794; 2003.
78. Olson, T. S.; Ley, K. Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283(1):R7-28; 2002.
79. Oluwole, S. F.; Oluwole, O. O.; DePaz, H. A.; Adeyeri, A. O.; Witkowski, P.; Hardy, M. A. CD4+CD25+ regulatory T cells mediate acquired transplant tolerance. Transpl. Immunol. 11(3-4):287-293; 2003.
80. Pabst, O.; Ohl, L.; Wendland, M.; Wurbel, M. A.; Kremmer, E.; Malissen, B.; Forster, R. Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine. J. Exp. Med. 199(3):411-416; 2004.
81. Paraskevas, S.; Maysinger, D.; Wang, R.; Duguid, T. P.; Rosenberg, L. Cell loss in isolated human islets occurs by apoptosis. Pancreas 20(3):270-276; 2000.
82. Piccirillo, C. A.; Shevach, E. M. Cutting edge: Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J. Immunol. 167(3):1137-1140; 2001.
83. Piemonti, L.; Leone, B. E.; Nano, R.; Saccani, A.; Monti, P.; Maffi, P.; Bianchi, G.; Sica, A.; Peri, G.; Melzi, R.; et al. Human pancreatic islets produce and secrete MCP-1/CCL2: Relevance in human islet transplantation. Diabetes 51(1):55-65; 2002.
84. Pierer, M.; Rethage, J.; Seibl, R.; Lauener, R.; Brentano, F.; Wagner, U.; Hantzschel, H.; Michel, B. A.; Gay, R. E.; Gay, S.; et al. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J. Immunol. 172(2):1256-1265; 2004.
85. Pilkington, K. R.; Clark-Lewis, I.; McColl, S. R. Inhibition of generation of cytotoxic T lymphocyte activity by a CCL19/macrophage inflammatory protein (MIP)-3beta antagonist. J. Biol. Chem. 279(39):40276-40182; 2004.
86. Ricordi, C.; Fraker, C.; Szust, J.; Al-Abdullah, I.; Poggioli, R.; Kirlew, T.; Khan, A.; Alejandro, R. Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution. Transplantation 75(9):1524-1527; 2003.
87. Rossi, D.; Zlotnik, A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:217-242; 2000.
88. Rusconi, S.; Scozzafava, A.; Mastrolorenzo, A.; Supuran, C. T. New advances in HIV entry inhibitors development. Curr. Drug Targets Infect. Disord. 4(4):339-355; 2004.
89. Ryan, E. A.; Lakey, J. R.; Rajotte, R. V.; Korbutt, G. S.; Kin, T.; Imes, S.; Rabinovitch, A.; Elliott, J. F.; Bigam, D.; Kneteman, N. M.; et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50(4):710-719; 2001.
90. Sabroe, I.; Peck, M. J.; Van Keulen, B. J.; Jorritsma, A.; Simmons, G.; Clapham, P. R.; Williams, T. J.; Pease, J. E. A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry. J. Biol. Chem. 275(34):25985-25992; 2000.
91. Sallusto, F.; Kremmer, E.; Palermo, B.; Hoy, A.; Ponath, P.; Qin, S.; Forster, R.; Lipp, M.; Lanzavecchia, A. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur. J. Immunol. 29(6):2037-2045; 1999.
92. Sallusto, F.; Lanzavecchia, A. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J. Exp. Med. 189(4):611-614; 1999.
93. Sallusto, F.; Mackay, C. R.; Lanzavecchia, A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18:593-620; 2000.
94. Sallusto, F.; Schaerli, P.; Loetscher, P.; Schaniel, C.; Lenig, D.; Mackay, C. R.; Qin, S.; Lanzavecchia, A. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28(9):2760-2769; 1998.
95. Sarween, N.; Chodos, A.; Raykundalia, C.; Khan, M.; Abbas, A. K.; Walker, L. S. CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J. Immunol. 173(5):2942-2951; 2004.
96. Sasaki, M.; Hasegawa, H.; Kohno, M.; Inoue, A.; Ito, M. R.; Fujita, S. Antagonist of secondary lymphoid-tissue chemokine (CCR ligand 21) prevents the development of chronic graft-versus-host disease in mice. J. Immunol. 170(1):588-596; 2003.
97. Schneider, G. P.; Salcedo, R.; Dong, H. F.; Kleinman, H. K.; Oppenheim, J. J.; Howard, O. M. Suradista NSC 651016 inhibits the angiogenic activity of CXCL12-stromal cell-derived factor 1alpha. Clin. Cancer Res. 8(12):3955-3960; 2002.
98. Schroppel, B.; Zhang, N.; Chen, P.; Zang, W.; Chen, D.; Hudkins, K. L.; Kuziel, W. A.; Sung, R.; Bromberg, J. S.; Murphy, B. Differential expression of chemokines and chemokine receptors in murine islet allografts: The role of CCR2 and CCR5 signaling pathways. J. Am. Soc. Nephrol. 15(7):1853-1861; 2004.
99. Shapiro, A. M.; Lakey, J. R.; Ryan, E. A.; Korbutt, G. S.; Toth, E.; Warnock, G. L.; Kneteman, N. M.; Rajotte, R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343(4):230-238; 2000.
100. Sidiropoulos, P. I.; Boumpas, D. T. Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients. Lupus 13(5):391-397; 2004.
101. Smiley, S. T.; Csizmadia, V.; Gao, W.; Turka, L. A.; Hancock, W. W. Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction. Transplantation 70(3):415-419; 2000.
102. Solomon, M. F.; Kuziel, W. A.; Mann, D. A.; Simeonovic, C. J. The role of chemokines and their receptors in the rejection of pig islet tissue xenografts. Xenotransplantation 10(2):164-177; 2003.
103. Song, E.; Zou, H.; Yao, Y.; Proudfoot, A.; Antus, B.; Liu, S.; Jens, L.; Heemann, U. Early application of Met-RANTES ameliorates chronic allograft nephropathy. Kidney Int. 61(2):676-685; 2002.
104. Sozzani, S.; Allavena, P.; D'Amico, G.; Luini, W.; Bianchi, G.; Kataura, M.; Imai, T.; Yoshie, O.; Bonecchi, R.; Mantovani, A. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol. 161(3):1083-1086; 1998.
105. Sozzani, S.; Allavena, P.; Vecchi, A.; Mantovani, A. The role of chemokines in the regulation of dendritic cell trafficking. J. Leukoc. Biol. 66(1):1-9; 1999.
106. Stephens, L. A.; Mason, D. CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations. J. Immunol. 165(6):3105-3110; 2000.
107. Stephens, L. A.; Mottet, C.; Mason, D.; Powrie, F. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 31(4):1247-1254; 2001.
108. Street, C. N.; Lakey, J. R.; Shapiro, A. M.; Imes, S.; Rajotte, R. V.; Ryan, E. A.; Lyon, J. G.; Kin, T.; Avila, J.; Tsujimura, T.; et al. Islet graft assessment in the edmonton protocol: Implications for predicting long-term clinical outcome. Diabetes 53(12):3107-3114; 2004.
109. Szanya, V.; Ermann, J.; Taylor, C.; Holness, C.; Fathman, C. G. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169(5):2461-2465; 2002.
110. Tanaka, Y.; Fujii, K.; Hubscher, S.; Aso, M.; Takazawa, A.; Saito, K.; Ota, T.; Eto, S. Heparan sulfate proteoglycan on endothelium efficiently induces integrin-mediated T cell adhesion by immobilizing chemokines in patients with rheumatoid synovitis. Arthritis Rheum. 41(8):1365-1377; 1998.
111. Tatapudi, R. R.; Muthukumar, T.; Dadhania, D.; Ding, R.; Li, B.; Sharma, V. K.; Lozada-Pastorio, E.; Seetharamu, N.; Hartono, C.; Serur, D.; et al. Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int. 65(6):2390-2397; 2004.
112. Taylor, P. A.; Noelle, R. J.; Blazar, B. R. CD4(+) CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J. Exp. Med. 193(11):1311-1318; 2001.
113. Unsoeld, H.; Krautwald, S.; Voehringer, D.; Kunzendorf, U.; Pircher, H. Cutting edge: CCR7+ and CCR7- memory T cells do not differ in immediate effector cell function. J. Immunol. 169(2):638-641; 2002.
114. Utgaard, J. O.; Jahnsen, F. L.; Bakka, A.; Brandtzaeg, P.; Haraldsen, G. Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells. J. Exp. Med. 188(9):1751-1756; 1998.
115. Vecchi, A.; Massimiliano, L.; Ramponi, S.; Luini, W.; Bernasconi, S.; Bonecchi, R.; Allavena, P.; Parmentier, M.; Mantovani, A.; Sozzani, S. Differential responsiveness to constitutive vs. inducible chemokines of immature and mature mouse dendritic cells. J. Leukoc. Biol. 66(3):489-494; 1999.
116. Vieira, P. L.; de Jong, E. C.; Wierenga, E. A.; Kapsenberg, M. L.; Kalinski, P. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J. Immunol. 164(9):4507-4512; 2000.
117. Waldmann, H.; Cobbold, S. Regulating the immune response to transplants. A role for CD4+ regulatory cells? Immunity 14(4):399-406; 2001.
118. Yopp, A. C.; Fu, S.; Honig, S. M.; Randolph, G. J.; Ding, Y.; Krieger, N. R.; Bromberg, J. S. FTY720-enhanced T cell homing is dependent on CCR2, CCR5, CCR7, and CXCR4: Evidence for distinct chemokine compartments. J. Immunol. 173(2):855-865; 2004.
119. Zhang, N.; Schroppel, B.; Chen, D.; Fu, S.; Hudkins, K. L.; Zhang, H.; Murphy, B. M.; Sung, R. S.; Bromberg, J. S. Adenovirus transduction induces expression of multiple chemokines and chemokine receptors in murine beta cells and pancreatic islets. Am. J. Transplant. 3(10):1230-1241; 2003.
120. Zhang, Z.; Kaptanoglu, L.; Tang, Y.; Ivancic, D.; Rao, S. M.; Luster, A.; Barrett, T. A.; Fryer, J. IP-10-induced recruitment of CXCR3 host T cells is required for small bowel allograft rejection. Gastroenterology 126(3):809-818; 2004.
121. Zlotnik, A.; Yoshie, O. Chemokines: A new classification system and their role in immunity. Immunity 12(2):121-127; 2000.